#' Inotuzumab ozogamicin data
#'
#' Phase 3 clinical trial which compared the effects of inotuzumab ozogamicin (group 1) with standard chemotherapy (group 0)
#' for treating of acute lymphoblastic leulemia. This dataset is obtained by re-digitizing the KM curves from the original medical paper.
#' Kantarjian HM, DeAngelo DJ, Stelljes M, et al. Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia. N Engl J Med. 2016;375(8):740-753.
#'
#'
#' @format ## `Inotuzumab`
#' A data frame with 1621 rows and 3 columns:
#' \describe{
#'   \item{surv.time}{the survival of each subject in the trial}
#'   \item{event}{censoring indicator}
#'   \item{arm}{treatment arm}
#' }
#' @source <https://www.nejm.org/doi/full/10.1056/nejmoa1509277>
"Inotuzumab"
